data_1m8l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m8l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mmm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.142 0.02 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -76.52 -177.06 3.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 110.784 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -79.7 58.79 2.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.766 1.226 . . . . 0.0 109.308 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.89 116.36 26.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.886 1.275 . . . . 0.0 111.844 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -81.35 -179.61 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.109 2.539 . . . . 0.0 109.546 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -59.72 -62.1 2.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.222 0.609 . . . . 0.0 109.386 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.02 83.52 7.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -67.19 95.82 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.911 0.885 . . . . 0.0 110.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.87 -168.91 43.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.37 0.986 . . . . 0.0 110.737 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.07 70.85 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.307 3.338 . . . . 0.0 109.757 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -83.12 84.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.343 1.457 . . . . 0.0 109.102 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -77.78 96.63 4.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.687 0.395 . . . . 0.0 111.248 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.21 85.27 0.17 Allowed Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.586 1.955 . . . . 0.0 114.667 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.04 -63.16 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.742 2.961 . . . . 0.0 109.839 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -72.07 163.58 27.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.47 41.25 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.048 0.928 . . . . 0.0 109.647 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.83 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.689 2.396 . . . . 0.0 105.378 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -62.1 -44.47 96.58 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -51.22 -50.93 58.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.266 1.426 . . . . 0.0 110.984 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.65 -29.16 69.12 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.037 0.935 . . . . 0.0 111.629 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -44.76 65.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.465 1.506 . . . . 0.0 111.791 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.03 -43.45 98.66 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.967 0.907 . . . . 0.0 109.428 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.3 -58.27 8.39 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.135 0.974 . . . . 0.0 109.624 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -49.76 -37.08 28.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 112.493 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.65 -54.12 31.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.956 0.902 . . . . 0.0 110.528 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.78 -33.1 74.92 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.611 0.569 . . . . 0.0 110.989 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -67.26 -47.73 69.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.222 1.009 . . . . 0.0 110.554 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -59.74 -47.79 84.25 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 123.854 0.721 . . . . 0.0 110.289 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -51.95 -53.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.557 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.02 40.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.754 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -28.83 45.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-N 119.82 1.191 . . . . 0.0 114.017 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -55.63 -54.4 44.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.396 0.617 . . . . 0.0 110.103 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -75.71 -32.3 60.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.149 1.78 . . . . 0.0 112.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -124.42 71.51 56.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.145 . . . . 0.0 110.511 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.65 74.61 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.943 3.095 . . . . 0.0 108.426 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -102.35 -38.61 7.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.293 1.437 . . . . 0.0 113.104 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.21 -22.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.088 1.755 . . . . 0.0 111.663 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -45.65 -40.48 9.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.885 1.674 . . . . 0.0 111.353 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.2 mt -36.86 -49.9 0.83 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.835 2.054 . . . . 0.0 111.464 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -64.27 -52.81 56.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.328 1.451 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -58.6 -39.36 80.21 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 111.991 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.5 -39.67 91.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.299 0.64 . . . . 0.0 110.763 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.17 92.19 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -57.87 -47.51 82.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.157 0.583 . . . . 0.0 110.161 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -58.3 -43.77 88.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 111.375 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -66.09 -22.63 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.325 0.65 . . . . 0.0 111.423 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -71.35 -28.46 64.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 110.834 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.65 -48.04 35.35 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.6 m -70.69 -44.71 66.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.371 1.468 . . . . 0.0 114.756 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -115.92 -48.51 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.21 1.404 . . . . 0.0 111.005 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.27 39.6 2.79 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 42.6 48.95 4.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 111.84 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -69.35 144.11 53.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -52.69 -25.99 12.6 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -62.71 -55.08 30.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.74 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.31 85.78 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.838 1.209 . . . . 0.0 112.658 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.94 -54.62 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.985 0.914 . . . . 0.0 110.093 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -59.99 -42.31 93.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.22 0.608 . . . . 0.0 110.892 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.04 72.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.247 1.019 . . . . 0.0 111.463 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.78 -48.85 78.51 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.485 0.714 . . . . 0.0 109.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 mm -63.62 -38.33 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 123.609 0.568 . . . . 0.0 110.387 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.49 -46.98 83.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.918 0.326 . . . . 0.0 110.959 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.3 -40.68 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 122.968 0.507 . . . . 0.0 110.449 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.31 -45.68 83.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 110.508 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -56.99 -48.35 78.64 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.315 1.446 . . . . 0.0 111.137 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -59.59 -52.23 66.43 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.357 0.663 . . . . 0.0 110.588 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.99 -44.05 70.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.577 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -55.09 38.03 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -47.59 -39.92 17.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 125.086 1.491 . . . . 0.0 111.223 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.62 -52.84 52.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.638 0.654 . . . . 0.0 110.526 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -71.05 -20.65 62.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.965 0.506 . . . . 0.0 112.057 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.66 -40.57 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.971 2.108 . . . . 0.0 108.166 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -62.08 -52.23 64.76 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.921 0.888 . . . . 0.0 109.511 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.1 mt -56.99 -48.14 82.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.392 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.07 -38.56 66.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.667 1.127 . . . . 0.0 113.139 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.57 -50.33 52.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.279 0.632 . . . . 0.0 110.667 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -69.73 -71.75 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 110.764 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -72.25 135.34 46.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.883 1.673 . . . . 0.0 109.286 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -56.06 -56.15 24.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.076 0.951 . . . . 0.0 109.958 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 44.58 67.78 0.64 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.774 2.429 . . . . 0.0 109.989 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.9 mt -79.31 64.38 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.565 1.546 . . . . 0.0 107.685 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.99 35.35 89.3 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.589 1.09 . . . . 0.0 111.065 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.34 66.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -70.62 -51.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.8 141.17 58.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.276 1.031 . . . . 0.0 108.849 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -47.86 -47.92 31.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 112.123 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.38 152.94 18.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -63.67 -51.67 64.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 p -77.67 -75.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.598 1.159 . . . . 0.0 111.544 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.7 128.35 19.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.462 1.105 . . . . 0.0 108.513 -174.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -51.59 153.54 2.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.023 1.329 . . . . 0.0 112.943 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.28 -77.62 1.82 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.3 -80.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.6 1.96 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -154.88 137.8 15.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.395 1.478 . . . . 0.0 107.616 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 51.97 61.33 3.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.864 1.265 . . . . 0.0 109.579 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.271 2.189 0 C-N-CA 125.704 1.601 . . . . 0.0 112.293 -174.778 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mmm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.142 0.02 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -76.52 -177.06 3.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 110.784 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -79.7 58.79 2.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.766 1.226 . . . . 0.0 109.308 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.89 116.36 26.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.886 1.275 . . . . 0.0 111.844 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -81.35 -179.61 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.109 2.539 . . . . 0.0 109.546 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -59.72 -62.1 2.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.222 0.609 . . . . 0.0 109.386 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.02 83.52 7.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -67.19 95.82 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.911 0.885 . . . . 0.0 110.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.87 -168.91 43.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.37 0.986 . . . . 0.0 110.737 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.07 70.85 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.307 3.338 . . . . 0.0 109.757 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -83.12 84.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.343 1.457 . . . . 0.0 109.102 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -77.78 96.63 4.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.687 0.395 . . . . 0.0 111.248 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.21 85.27 0.17 Allowed Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.586 1.955 . . . . 0.0 114.667 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.04 -63.16 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.742 2.961 . . . . 0.0 109.839 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -72.07 163.58 27.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.47 41.25 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.048 0.928 . . . . 0.0 109.647 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.83 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.689 2.396 . . . . 0.0 105.378 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -62.1 -44.47 96.58 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -51.22 -50.93 58.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.266 1.426 . . . . 0.0 110.984 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.65 -29.16 69.12 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.037 0.935 . . . . 0.0 111.629 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -44.76 65.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.465 1.506 . . . . 0.0 111.791 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.03 -43.45 98.66 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.967 0.907 . . . . 0.0 109.428 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.3 -58.27 8.39 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.135 0.974 . . . . 0.0 109.624 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -49.76 -37.08 28.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 112.493 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.65 -54.12 31.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.956 0.902 . . . . 0.0 110.528 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.78 -33.1 74.92 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.611 0.569 . . . . 0.0 110.989 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -67.26 -47.73 69.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.222 1.009 . . . . 0.0 110.554 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -59.74 -47.79 84.25 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 123.854 0.721 . . . . 0.0 110.289 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -51.95 -53.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.557 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.02 40.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.754 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -28.83 45.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-N 119.82 1.191 . . . . 0.0 114.017 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -55.63 -54.4 44.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.396 0.617 . . . . 0.0 110.103 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -75.71 -32.3 60.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.149 1.78 . . . . 0.0 112.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -124.42 71.51 56.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.145 . . . . 0.0 110.511 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.65 74.61 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.943 3.095 . . . . 0.0 108.426 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -102.35 -38.61 7.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.293 1.437 . . . . 0.0 113.104 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.21 -22.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.088 1.755 . . . . 0.0 111.663 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -45.65 -40.48 9.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.885 1.674 . . . . 0.0 111.353 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.2 mt -36.86 -49.9 0.83 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.835 2.054 . . . . 0.0 111.464 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -64.27 -52.81 56.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.328 1.451 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -58.6 -39.36 80.21 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 111.991 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.5 -39.67 91.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.299 0.64 . . . . 0.0 110.763 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.17 92.19 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -57.87 -47.51 82.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.157 0.583 . . . . 0.0 110.161 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -58.3 -43.77 88.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 111.375 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -66.09 -22.63 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.325 0.65 . . . . 0.0 111.423 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -71.35 -28.46 64.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 110.834 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.65 -48.04 35.35 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.6 m -70.69 -44.71 66.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.371 1.468 . . . . 0.0 114.756 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -115.92 -48.51 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.21 1.404 . . . . 0.0 111.005 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.27 39.6 2.79 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 42.6 48.95 4.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 111.84 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -69.35 144.11 53.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -52.69 -25.99 12.6 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -62.71 -55.08 30.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.74 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.31 85.78 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.838 1.209 . . . . 0.0 112.658 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.94 -54.62 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.985 0.914 . . . . 0.0 110.093 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -59.99 -42.31 93.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.22 0.608 . . . . 0.0 110.892 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.04 72.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.247 1.019 . . . . 0.0 111.463 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.78 -48.85 78.51 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.485 0.714 . . . . 0.0 109.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 mm -63.62 -38.33 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 123.609 0.568 . . . . 0.0 110.387 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.49 -46.98 83.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.918 0.326 . . . . 0.0 110.959 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.3 -40.68 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 122.968 0.507 . . . . 0.0 110.449 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.31 -45.68 83.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 110.508 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -56.99 -48.35 78.64 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.315 1.446 . . . . 0.0 111.137 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -59.59 -52.23 66.43 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.357 0.663 . . . . 0.0 110.588 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.99 -44.05 70.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.577 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -55.09 38.03 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -47.59 -39.92 17.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 125.086 1.491 . . . . 0.0 111.223 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.62 -52.84 52.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.638 0.654 . . . . 0.0 110.526 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -71.05 -20.65 62.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.965 0.506 . . . . 0.0 112.057 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.66 -40.57 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.971 2.108 . . . . 0.0 108.166 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -62.08 -52.23 64.76 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.921 0.888 . . . . 0.0 109.511 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.1 mt -56.99 -48.14 82.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.392 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.07 -38.56 66.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.667 1.127 . . . . 0.0 113.139 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.57 -50.33 52.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.279 0.632 . . . . 0.0 110.667 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -69.73 -71.75 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 110.764 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -72.25 135.34 46.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.883 1.673 . . . . 0.0 109.286 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -56.06 -56.15 24.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.076 0.951 . . . . 0.0 109.958 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 44.58 67.78 0.64 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.774 2.429 . . . . 0.0 109.989 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.9 mt -79.31 64.38 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.565 1.546 . . . . 0.0 107.685 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.99 35.35 89.3 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.589 1.09 . . . . 0.0 111.065 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.34 66.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -70.62 -51.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.8 141.17 58.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.276 1.031 . . . . 0.0 108.849 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -47.86 -47.92 31.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 112.123 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.38 152.94 18.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -63.67 -51.67 64.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 p -77.67 -75.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.598 1.159 . . . . 0.0 111.544 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.7 128.35 19.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.462 1.105 . . . . 0.0 108.513 -174.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -51.59 153.54 2.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.023 1.329 . . . . 0.0 112.943 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.28 -77.62 1.82 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.3 -80.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.6 1.96 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -154.88 137.8 15.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.395 1.478 . . . . 0.0 107.616 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 51.97 61.33 3.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.864 1.265 . . . . 0.0 109.579 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.271 2.189 0 C-N-CA 125.704 1.601 . . . . 0.0 112.293 -174.778 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.0 mmm . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 120.142 0.02 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -76.52 -177.06 3.99 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.472 0.709 . . . . 0.0 110.784 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -79.7 58.79 2.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.766 1.226 . . . . 0.0 109.308 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -63.89 116.36 26.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 124.886 1.275 . . . . 0.0 111.844 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -81.35 -179.61 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 123.109 2.539 . . . . 0.0 109.546 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -59.72 -62.1 2.12 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.222 0.609 . . . . 0.0 109.386 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -82.02 83.52 7.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -67.19 95.82 0.43 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.911 0.885 . . . . 0.0 110.164 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.87 -168.91 43.63 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.37 0.986 . . . . 0.0 110.737 174.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.07 70.85 5.88 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.307 3.338 . . . . 0.0 109.757 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -83.12 84.74 7.36 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.343 1.457 . . . . 0.0 109.102 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -77.78 96.63 4.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.687 0.395 . . . . 0.0 111.248 -174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 45.21 85.27 0.17 Allowed Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 126.586 1.955 . . . . 0.0 114.667 174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -55.04 -63.16 0.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.742 2.961 . . . . 0.0 109.839 174.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -72.07 163.58 27.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 57.47 41.25 26.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.048 0.928 . . . . 0.0 109.647 -173.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -167.83 -61.71 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 127.689 2.396 . . . . 0.0 105.378 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.1 t90 -62.1 -44.47 96.58 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.2 m -51.22 -50.93 58.14 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.266 1.426 . . . . 0.0 110.984 175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.65 -29.16 69.12 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 124.037 0.935 . . . . 0.0 111.629 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.89 -44.76 65.61 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.465 1.506 . . . . 0.0 111.791 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 77.4 mt -63.03 -43.45 98.66 Favored 'General case' 0 C--N 1.338 0.092 0 C-N-CA 123.967 0.907 . . . . 0.0 109.428 176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -55.3 -58.27 8.39 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 124.135 0.974 . . . . 0.0 109.624 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -49.76 -37.08 28.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.333 1.453 . . . . 0.0 112.493 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.65 -54.12 31.9 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.956 0.902 . . . . 0.0 110.528 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.78 -33.1 74.92 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 123.611 0.569 . . . . 0.0 110.989 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -67.26 -47.73 69.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.222 1.009 . . . . 0.0 110.554 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -59.74 -47.79 84.25 Favored 'General case' 0 CA--C 1.52 -0.189 0 O-C-N 123.854 0.721 . . . . 0.0 110.289 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -51.95 -53.31 42.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.557 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.11 -54.02 40.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 117.811 -1.09 . . . . 0.0 111.754 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -63.84 -28.83 45.77 Favored 'Isoleucine or valine' 0 C--N 1.341 0.216 0 CA-C-N 119.82 1.191 . . . . 0.0 114.017 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -55.63 -54.4 44.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.396 0.617 . . . . 0.0 110.103 174.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -75.71 -32.3 60.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.149 1.78 . . . . 0.0 112.453 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -124.42 71.51 56.83 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 127.061 2.145 . . . . 0.0 110.511 -173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.65 74.61 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.943 3.095 . . . . 0.0 108.426 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -102.35 -38.61 7.54 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.293 1.437 . . . . 0.0 113.104 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 78.21 -22.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.088 1.755 . . . . 0.0 111.663 -174.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -45.65 -40.48 9.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 125.885 1.674 . . . . 0.0 111.353 174.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.2 mt -36.86 -49.9 0.83 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.835 2.054 . . . . 0.0 111.464 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -64.27 -52.81 56.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.328 1.451 . . . . 0.0 110.927 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.2 t -58.6 -39.36 80.21 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.187 0.995 . . . . 0.0 111.991 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 87.4 mt -61.5 -39.67 91.81 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.299 0.64 . . . . 0.0 110.763 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.54 -47.17 92.19 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.794 -0.522 . . . . 0.0 111.794 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -57.87 -47.51 82.52 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.157 0.583 . . . . 0.0 110.161 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -58.3 -43.77 88.22 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 111.375 174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 8.5 mt -66.09 -22.63 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.325 0.65 . . . . 0.0 111.423 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -71.35 -28.46 64.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 110.834 172.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -73.65 -48.04 35.35 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.6 m -70.69 -44.71 66.4 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.371 1.468 . . . . 0.0 114.756 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -115.92 -48.51 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.21 1.404 . . . . 0.0 111.005 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.27 39.6 2.79 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 42.6 48.95 4.77 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.835 2.054 . . . . 0.0 111.84 -170.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.4 m -69.35 144.11 53.55 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -52.69 -25.99 12.6 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 m -62.71 -55.08 30.01 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.945 0.898 . . . . 0.0 109.74 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.64 -33.31 85.78 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.838 1.209 . . . . 0.0 112.658 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.94 -54.62 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 123.985 0.914 . . . . 0.0 110.093 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -59.99 -42.31 93.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.22 0.608 . . . . 0.0 110.892 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.36 -50.04 72.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.247 1.019 . . . . 0.0 111.463 175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.4 tp -57.78 -48.85 78.51 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.485 0.714 . . . . 0.0 109.991 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.6 mm -63.62 -38.33 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 123.609 0.568 . . . . 0.0 110.387 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -63.49 -46.98 83.64 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 117.918 0.326 . . . . 0.0 110.959 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.4 mt -68.3 -40.68 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 122.968 0.507 . . . . 0.0 110.449 -178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -65.31 -45.68 83.39 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.231 1.012 . . . . 0.0 110.508 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -56.99 -48.35 78.64 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.315 1.446 . . . . 0.0 111.137 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -59.59 -52.23 66.43 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.357 0.663 . . . . 0.0 110.588 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 tt -53.99 -44.05 70.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.577 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -55.09 38.03 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -47.59 -39.92 17.93 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 125.086 1.491 . . . . 0.0 111.223 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.62 -52.84 52.43 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-N 118.638 0.654 . . . . 0.0 110.526 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -71.05 -20.65 62.35 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.965 0.506 . . . . 0.0 112.057 -176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -81.66 -40.57 22.67 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.971 2.108 . . . . 0.0 108.166 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.3 ttt85 -62.08 -52.23 64.76 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.921 0.888 . . . . 0.0 109.511 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 97.1 mt -56.99 -48.14 82.21 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.392 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.07 -38.56 66.53 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.667 1.127 . . . . 0.0 113.139 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.57 -50.33 52.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.279 0.632 . . . . 0.0 110.667 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -69.73 -71.75 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.976 0.91 . . . . 0.0 110.764 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -72.25 135.34 46.01 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 125.883 1.673 . . . . 0.0 109.286 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.4 t -56.06 -56.15 24.34 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.076 0.951 . . . . 0.0 109.958 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 44.58 67.78 0.64 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.774 2.429 . . . . 0.0 109.989 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 17.9 mt -79.31 64.38 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.565 1.546 . . . . 0.0 107.685 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.99 35.35 89.3 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.589 1.09 . . . . 0.0 111.065 -174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.7 mt -90.34 66.68 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.199 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 83.8 mt -70.62 -51.94 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -65.8 141.17 58.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.276 1.031 . . . . 0.0 108.849 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -47.86 -47.92 31.38 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.788 1.235 . . . . 0.0 112.123 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.38 152.94 18.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 174.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.2 tpm_? -63.67 -51.67 64.09 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 p -77.67 -75.66 0.21 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.598 1.159 . . . . 0.0 111.544 -174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.7 128.35 19.2 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.462 1.105 . . . . 0.0 108.513 -174.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -51.59 153.54 2.26 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.023 1.329 . . . . 0.0 112.943 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.28 -77.62 1.82 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.3 -80.74 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.6 1.96 . . . . 0.0 112.44 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.3 t -154.88 137.8 15.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.395 1.478 . . . . 0.0 107.616 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.7 tttp 51.97 61.33 3.27 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.864 1.265 . . . . 0.0 109.579 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.271 2.189 0 C-N-CA 125.704 1.601 . . . . 0.0 112.293 -174.778 . . . . . . . . 0 0 . 1 stop_ save_